Tonix Pharmaceuticals Holding (TNXP) EPS (Weighted Average and Diluted): 2023-2025
Historic EPS (Weighted Average and Diluted) for Tonix Pharmaceuticals Holding (TNXP) over the last 2 years, with Sep 2025 value amounting to -$3.59.
- Tonix Pharmaceuticals Holding's EPS (Weighted Average and Diluted) rose 84.17% to -$3.59 in Q3 2025 from the same period last year, while for Sep 2025 it was $279.28, marking a year-over-year increase of 101.64%. This contributed to the annual value of -$176.60 for FY2024, which is 98.80% up from last year.
- Latest data reveals that Tonix Pharmaceuticals Holding reported EPS (Weighted Average and Diluted) of -$3.59 as of Q3 2025, which was up 6.99% from -$3.86 recorded in Q2 2025.
- In the past 5 years, Tonix Pharmaceuticals Holding's EPS (Weighted Average and Diluted) registered a high of $289.57 during Q4 2024, and its lowest value of -$14,577 during Q4 2023.
- Over the past 3 years, Tonix Pharmaceuticals Holding's median EPS (Weighted Average and Diluted) value was -$22.68 (recorded in 2024), while the average stood at -$1,868.
- Data for Tonix Pharmaceuticals Holding's EPS (Weighted Average and Diluted) shows a peak YoY skyrocketed of 101.99% (in 2024) over the last 5 years.
- Tonix Pharmaceuticals Holding's EPS (Weighted Average and Diluted) (Quarterly) stood at -$14,577 in 2023, then surged by 101.99% to $289.57 in 2024, then soared by 84.17% to -$3.59 in 2025.
- Its last three reported values are -$3.59 in Q3 2025, -$3.86 for Q2 2025, and -$2.84 during Q1 2025.